• Reset
SWHR Supports Reintroduction of the Research For All Act

United States Representatives Jim Cooper (D-TN) and Cynthia Lummis (R-WY) introduced the “Research for All Act of 2015” in Congress.

SWHR Expresses Concern with USPSTF’s Mammography Guideline Update

The United States Preventative Services Taskforce (USPSTF) released a new set of mammography guidelines, the first since the taskforce’s controversial 2009 update.

SWHR Praises “The Battle For Women’s Hearts – And Lives” Commentary

SWHR commends Barbra Streisand for her commentary in The Washington Post, titled, “The Battle For Women’s Hearts – And Lives,” and for bringing into the public eye the work that SWHR has been doing for 25 years.

SWHR Praises Equal but not the same: a male bias reigns in medical research Commentary

SWHR commends Peter Rogers, Professor of Women’s Health Research, Department of Obstetrics and Gynecology, and Director of Research, Royal Women's Hospital at University of Melbourne for his commentary in Equal but not the same: a male bias reigns in medical research.

SWHR Statement in Appreciation for Commissioner Hamburg’s Service

SWHR commends the outgoing Food and Drug Administration (FDA) Commissioner, Dr. Margaret Hamburg, for her profound service to improve American public health at the Agency.

SWHR Statement on President’s Budget and Precision Medicine Initiative

President Barack Obama unveiled his budget request to Congress for the 2016 fiscal year, which provides for critical investment in research at our Nation’s premier science agencies.

DeLauro NIH Funding Bill Will Provide Critically Needed Investments in Medical Research

Statement from Phyllis Greenberger, President and CEO of the Society for Women’s Health Research

SWHR Submits comments to FDA Regarding Drug Trials Snapshots

The U.S. Food and Drug Administration (FDA) recently created Drug Trials Snapshots, a new website to give patients, providers, and caregivers information on the participation of people in clinical trials by sex, age, race, and ethnicity.

FDA Issues Final Rule on Pregnancy and Lactation Labeling

The Food and Drug Administration announced a final rule today that sets new standards for labeling information for prescription drugs and biological products.

SWHR Salutes the FDA Office of Women’s Health on 20 Years of Advancing Women’s Health

SWHR congratulates the Food and Drug Administration’s (FDA) Office of Women’s Health for 20 years of working to improve the health of women.